Aveanna (AVAH) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Aveanna Healthcare (AVAH) reported revenue of $509.02 million for Q3 2024, marking a year-over-year increase of 6.5% and exceeding the Zacks Consensus Estimate by 2.67% [1] - The company achieved an EPS of $0.02, a significant improvement from -$0.03 a year ago, resulting in an EPS surprise of 300.00% compared to the consensus estimate of -$0.01 [1] Financial Performance Metrics - Hours - PDS: 10,474 hours, surpassing the estimated 10,301.9 hours [3] - Revenue rate - MS: $492.67, compared to the average estimate of $454.77 [3] - Unique patients served (UPS) - MS: 92, matching the estimated average [3] - Revenue rate - PDS: $39.10, exceeding the average estimate of $38.66 [3] - Revenue - PDS: $409.56 million, above the estimated $399.42 million, reflecting a 6.5% year-over-year change [3] - Revenue - MS: $45.33 million, compared to the estimated $41.66 million, indicating a year-over-year change of 12.6% [3] - Revenue - HHH: $54.14 million, slightly above the estimated $53.32 million, with a year-over-year change of 2.2% [3] Stock Performance - Aveanna's shares have returned +3% over the past month, in line with the Zacks S&P 500 composite's +3.2% change [4] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [4]